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Objectives: Muscle injury due to crushing (muscle compression injury) is associated with
systemic manifestations known as crush syndrome. A systemic inﬂammatory reaction
may also be triggered by isolated muscle injury. The aim of this study was to investigate
the plasma levels of interleukins (IL) 1, 6 and 10 and tumor necrosis factor alpha (TNF-
),  which are markers for possible systemic inﬂammatory reactions, after isolated muscle
injury resulting from lower-limb compression in rats.
Methods: Male Wistar rats were subjected to 1 h of compression of their lower limbs by means
of  a rubber band. The plasma levels of IL 1, 6 and 10 and TNF- were measured 1, 2 and 4 h
after the rats were released from compression.
Results: The plasma levels of IL 10 decreased in relation to those of the other groups, with a
statistically signiﬁcant difference (p < 0.05). The method used did not detect the presence of
IL  1, IL 6 or TNF-.
Conclusion: Our results demonstrated that the changes in plasma levels of IL 10 that were
found may have been a sign of the presence of circulating interleukins in this model of
lower-limb compression in rats.
© 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. All rights reserved.
Expressão  de  citoquinas  plasmáticas  após  compressão  de  membros
inferiores  de  ratosalavras-chave:
índrome de esmagamento
r  e  s  u  m  o
Objetivos: A lesão muscular por esmagamento (lesão por compressão muscular) está asso-
ciada a manifestac¸ões sistêmicas conhecidas como síndrome do esmagamento. A reac¸ão
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Modelos animais
Interleucinas
Fator de necrose tumoral 
inﬂamatória sistêmica pode também ser desencadeada pela lesão muscular isolada. O obje-
tivo  deste estudo foi investigar os níveis plasmáticos de interleucinas (IL) 1, 6, 10 e TNF-,
marcadores de uma possível reac¸ão inﬂamatória sistêmica, após a lesão muscular isolada
resultante da compressão de membros inferiores de ratos.
Métodos: Ratos Wistar machos foram submetidos a uma hora de compressão dos membros
inferiores por uma faixa de borracha. Os níveis plasmáticos de IL 1, 6, 10 e TNF- foram
medidos uma, duas e quatro horas após a liberac¸ão da compressão.
Resultados: Os níveis plasmáticos de IL 10 diminuíram quando comparados com outros gru-
pos com diferenc¸a estatisticamente signiﬁcante (p < 0,05). Não houve detecc¸ão, pelo método,
da  presenc¸a de IL 1, 6 e TNF-.
Conclusão: Nossos resultados demonstraram que as alterac¸ões dos níveis plasmáticos de IL
10  encontradas podem ser um sinal da presenc¸a de interleucinas circulantes nesse modelo
de  compressão de membros inferiores de ratos.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Todos os direitos reservados.Introduction
It has been well established that musculoskeletal trauma is
associated with a signiﬁcant inﬂammatory response mediated
by a complex biological system of chemical mediators.1 These
mechanisms are present in muscle injuries.2 In addition to
the local inﬂammatory response, distant organs are subject to
the effects of these mediators.3 The systemic inﬂammatory
response syndrome (SIRS) is a severe complication from this
process.1,4
The crush syndrome is a systemic repercussion from mus-
cle injuries, especially when the lower limbs are affected.5 The
type of muscle injury associated with crush syndrome occurs
through compression, such as in the situation of victims under
debris. Classically, there is extravasation of myoglobin in the
circulation, with renal repercussions and in many  cases, kid-
ney failure.6 Other mechanisms related to crush syndrome
have been studied, with special interest in the inﬂammatory
response.7,8
Cytokines are chemical mediators that are studies in rela-
tion to inﬂammation and SIRS. They act as chemotactic factors
for inﬂammatory cells such as neutrophils and are capa-
ble of promoting systemic clinical responses such as pain
and fever.9 Production of anti-inﬂammatory cytokines occurs
simultaneously during the process, and this diminishes or
even eliminates the inﬂammation.10 Today, several different
cytokines are known. Among the ones that have been most
studied, interleukin (IL) 1, IL 6 and TNF- (tumor necrosis
factor alpha) are characterized by being strongly associated
with the inﬂammatory process. IL 10 is characterized by its
antagonist function in the relation to the ﬁrst three, i.e. its anti-
inﬂammatory action. The proportions between production of
pro and anti-inﬂammatory cytokines seem to determine the
severity of the inﬂammatory response.3
We  recently developed an experimental model for com-
pression of the lower limbs of rats with the characteristics of
a muscle injury due to crushing.8 With the aim of contribut-
ing towards understanding the physiopathology of muscle
compression at the cellular and molecular levels, we  inves-
tigated in the present paper, whether plasma cytokines are
present in rates subjected to lower-limb muscle compression,in an experimental model that simulates muscle injury due to
crushing.
Materials  and  methods
After obtaining approval from the ethics committee for animal
research, adult Wistar rats weighing 250–300 g (n = 24) were
deprived of food but continued to have free access to water
over a 12 h period before the experiments. The animals were
then subjected to general anesthesia (pentobarbital intraperi-
toneally, 30 mg/kg; and 2% xylazine intramuscularly, 5 mg/kg)
while spontaneous respiration was maintained for the start of
the experiments. After these 24 animals’ clinical condition had
been stabilized, they were randomized into four groups (n = 6):
three groups according to their lengths of survival after release
from compression (1 h, 6 h and 4 h) and a control group (n = 6).
A strip of elastic rubber (Esmarch bandage) of 10 cm in width
and 80 cm in length was ﬁrmly applied around both hind limbs
simultaneously, by the same researcher (Fig. 1). The pres-
sure produced by the bandage was measured as 300 mmHg,
using a variation of the Whitesides method, with the ban-
dage still applied (Fig. 2).11 After 1 h, the bandage was removed.
The anesthesia was topped up when necessary. In accordance
with the previous randomization, the rats were sacriﬁced 1,
2 or 4 h after removal of the bandage. The controls were kept
under general anesthesia for 4 h, without compression or any
other procedure. The rats were sacriﬁced using pentobarbi-
tal intraperitoneally, at a dose of 80 mg/kg and blood samples
(2 mL)  were collected by means of puncturing the heart using
a needle and syringe. The blood samples that were taken were
centrifuged immediately (4 ◦C) and the plasma was frozen
(−80 ◦C) for subsequent analysis on the cytokines. The exper-
imental design of this model was previously established and
used by our research group.8
Expression  of  interleukins  1,  6  and  10  and
TNF-Blood samples were collected (2 mL)  by means of cardiac
puncture immediately before the rats were sacriﬁced. The
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Fig. 1 – Esmarch bandage applied to the hind limbs,
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Fig. 2 – Modiﬁed Whitesides method: 15 mL  syringe ﬁlled
with air, with embolus under traction, connected to a
three-way tap that led to one plastic tube containing air
and another tube half-ﬁlled with physiological serum. One
tube connected to a mercury sphygmomanometer and the
other tube to a needle between the skin and the Esmarch
bandage. With the standardized application of the Esmarch
bandage (wrapped 10 times around the legs), the pressure
needed to move the liquid meniscus was 300 mmHg.
Diagram of the experiment (the scales do not correspond to
pro-inﬂammatory interleukins (IL 1, IL 6 and TNF-) and anti-rapped around them 10 times.
amples were centrifuged at 1000 g (4 ◦C) for 10 min  and the
upernatant (approximately 1 mL  of plasma) was placed
n Eppendorf plastic tubes and stored at −80 ◦C for subse-
uent analysis. The interleukins 1, 6 and 10 and TNF- were
xpressed in accordance with the manufacturer’s instructions
PharMingen – OptEia®, BD Biosciences, Franklin Lakes, NJ,
SA). Firstly, the speciﬁc antibodies were added to the wells
f the reading plate: biotinylated anti-rat IL 1, anti-rat IL 6,
nti-rat IL 10 or TNF- monoclonal antibodies (PharMingen –
ptEia®). The plates were incubated for 12 h (4 ◦C). The wells
ere washed ﬁve times with saline solution in phosphate
uffer (PBS) with 0.05% Tween-20 (polyoxyethylene sorbitan
onooleate, Sigma®, USA) (standard solution). Following this,
00 L of the saline solution in phosphate buffer (pH = 7.0) with
0% fetal bovine serum was added to the plates, which were
ncubated at 4 ◦C for 30 min. The plates were then washed
sing the standard solution. The ﬁrst column of the plate
eight wells) received 100 L of the antigen solution (IL 1, IL 6,
L 10 or TNF-) at increasing dilutions (PharMingen – OptEia®).
ollowing this, 100 L of each of the samples was added to
he cells of the second column (the ﬁrst column, as already
escribed, was reserved for construction of the standard curve
f each of the interleukins studied). Each sample was studied
n two contiguous cells so that we  would be able to use the
ean from the values obtained. The incubation period for this
hase was 2 h and this was again followed by washing the cells
ve times with the standard solution. Monoclonal antibodies
onded with biotin were added to the monoclonal plates
Biotinylated anti-rat; PharMingen – OptEia®). After incuba-
ion for 1 h, the wells were again washed using the standard
olution. At this stage, 100 L of horseradish peroxidase (HRP)
onjugated with avidin was incorporated into each well. The
lates were incubated for 30 min  and were washed seven
imes with the standard solution. In the ﬁnal stage, 100 Lreality in order make the method easier to understand).
of tetramethylbenzidine and hydrogen peroxide were added.
The plates were incubated for 30 min. The ﬁnal results were
obtained using a spectrophotometer (wavelength of 570 nm
for IL 1, IL 6 and IL 10; and wavelength of 450 nm for TNF-).
Statistical  analysis
The statistics were analyzed using the SigmaStat® software
(SigmaStat for Windows, version 1.0, copyright 1992–1994, Jan-
del Corporation). The nonparametric Kruskal–Wallis test was
used (ANOVA ranking test) and the results were described
in terms of the median and interquartile range. Post-tests
were then used to compare pairs in the groups. For this, the
Student–Newman–Keuls t-test was used. To compare pairs
after the Kruskal–Wallis test, the Dunn test was used.
Results
The animals’ plasma was investigated for the presence ofinﬂammatory interleukins (IL 10). Within the limits of the
method used, no presence of pro-inﬂammatory interleukins
was detected. On the other hand, IL 10 was found in all the
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Fig. 3 – Variations in plasma levels of interleukin 10 found
during the experiment. * Signiﬁcant when the groups
revaluated 1 and 4 h after release of the compression were
compared (p < 0.05).
animals studied and, after an initial increase, it presented
a progressive decline in plasma concentration (Fig. 1). The
means obtained were 0.09 pg/mL (range: 0.073–0.17 pg/mL) for
the control; 0.142 pg/mL (range: 0.085–0.259 pg/mL) for 1 h;
0.09 pg/mL (range: 0.061–0.121 pg/mL) for 2 h; and 0.03 pg/mL
(range: 0.020–0.047 pg/mL) for 4 h (Kruskal–Wallis Analysis of
Variance on Ranks). At the last study time (4 h after release
of the muscle compression), this decrease acquired statistical
signiﬁcance in relation to the 1 h group (Dunn test; p < 0.05)
(Fig. 3).
Discussion
There are several experimental models for studying injuries
due to muscle compression and crush syndrome.7,8,12–15 From
our model, the results demonstrated signiﬁcant alterations in
IL 10 levels, 4 h after release of the compression.
Although the most reproducible results have been found
through experimental models, clinical trials have correlated
high plasma cytokine levels and severe conditions presented
by patients with multiple traumatic injuries.16 Recently, mod-
els for crush syndrome have focused not only on the classical
ﬁndings of crush syndrome, but also on systemic alterations
related to the inﬂammatory response.7,8 However, among the
studies in the literature that we  reviewed, none of them corre-
lated crush syndrome with the production of interleukins 1, 6
and 10 and TNF- in the plasma, as seen in the present study.
Interleukins are polypeptides produced by inﬂammatory
cells and they act at sites close to where they are produced.17
Damaged muscle ﬁbers may produce cytokines such as TNF-
, IL 1  and IL 6 (2). When there is high production of
interleukins, extravasation of these substances to the plasma
occurs. Under these biological conditions, some of these
cytokines serve as triggers for a systemic inﬂammatory
reaction.17
Some interesting results have indicated that IL 10 has an
important regulatory role in immunological and inﬂammatory1 5;5 0(1):105–109
responses because of its capacity to inhibit the production of
pro-inﬂammatory cytokines by monocytes.18 IL 10 reduces the
levels of inﬂammation induced by TNF- in endothelial cells,
such as the production of reactive oxygen species and the
adherence of leukocytes to the endothelium.19 It is unclear
whether IL 10 is connected with muscle injury, but there is
some evidence that moderate to high levels of IL 10 inhibit the
production of IL 1 and IL 6 under such conditions.20 Our ﬁnd-
ings (increased IL 10 and non-identiﬁcation of inﬂammatory
cytokines) may be explained by these interactions between IL
10 and inﬂammatory cytokines.
In this model, pro-inﬂammatory cytokines were not found
in the plasma after the injury caused by the isolated compres-
sion of the hind limbs of the rats. In reviewing the literature, we
found data that may help in discussing why these substances
were not detected. There is some evidence that IL 6 may only
be produced in muscles that are contracted at the time of the
trauma.2 Because of the effect of the anesthesia, the muscles
in the model proposed here would have been relaxed at the
time of applying the compression, and this may corroborate
the negative results found regarding inﬂammatory cytokine
production. Furthermore, it is possible that subtle variations
in the concentrations of IL 1, IL 6 and TNF- may not have been
detected in this model due to the limits of the methodology
used or even because of the times that we chose for detection
of cytokines (1, 2 and 4 h), since it is known that interleukins
may have a half-life of only a few minutes. It is important
to emphasize that IL 10 was present 1 h after releasing the
compression and that there was a progressive decrease in its
plasma concentrations over the course of the experiment. As
stated earlier, studies have suggested that the ﬁnal inﬂamma-
tory reaction depends on the resultant between the pro- and
anti-inﬂammatory mediators.20 Indirectly, the decrease in the
plasma concentration of IL 10 may be related to the presence of
circulating IL 1, IL 6 and TNF-. In conclusion, although IL 10 is
an anti-inﬂammatory cytokine, the levels encountered may be
an indirect sign of the presence of inﬂammatory interleukins
in this model of muscle compression in rats.
Conclusions
Our experimental model for muscle injury due to compression
(muscle injury due to crushing) demonstrated the presence
and variation in levels of IL 10 in the plasma, with a peak
1 h after the compression was released and a decrease in the
values found, 4 h after this release.
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